November 8, 2024

Blink-182’s Mark Hoppus Reveals He Has Cancer: ‘It Sucks and I’m Scared’

Mark Hoppus #MarkHoppus

a man holding a guitar: Kevin Mazur/Getty © Provided by People Kevin Mazur/Getty

Blink-182 frontman Mark Hoppus has been diagnosed with cancer.

The bass guitarist and singer, 49, opened up about the diagnosis across his social media on Wednesday and revealed he’s started chemotherapy.

“For the past three months I’ve been undergoing chemotherapy for cancer. I have cancer,” Hoppus wrote. “It sucks and I’m scared, and at the same time I’m blessed with incredible doctors and family and friends to get me through this.”

“I still have months of treatment ahead of me but I’m trying to remain hopeful and positive,” he added.

“Can’t wait to be cancer free and see you all at a concert in the hopefully near future. Love to you all,” Hoppus concluded.

RELATED: Blink-182 Releases Quarantine Music Video for Song ‘Happy Days’ – Featuring Special Guest Stars!

Never miss a story – sign up for PEOPLE’s free daily newsletterto stay up-to-date on the best of what PEOPLE has to offer, from juicy celebrity news to compelling human interest stories.

Hoppus’ post comes hours after he posted and deleted a photo of him appearing to be at a doctor’s office.

In the picture, captured by a fan, the musician is seen sitting down with an IV. “Yes hello. One cancer treatment, please,” he wrote on the pic.

RELATED: Friends’ James Michael Tyler’s Stage 4 Cancer Has Moved to His Spine ‘But He’s Going to Fight This’

Since sharing his statement, several fans and stars have wished the Blink-182 bassist a speedy recovery.

“You’re on our minds, Mark,” tweeted B.J. Novak. “Your attitude is going to be magnified by so many people.”

“Sending you love and encouragement,” said Of Mice & Men’s Aaron Pauley.

“I love you Mark,” said musician Chet Porter. “Get well soon buddy.”

Travis Barker, Hoppus’ Blink-182 bandmate, also shared a photo of the two to his Instagram story – writing, “Love you, @markhoppus” and adding a heart emoji.

Leave a Reply